A sizable tomb of an as of yet unknown era of ancient Egypt was discovered by American archeologist Craig Morris from the International Archeological Research Institute (IARII) on yesterdays Wednesday, 8th of January, near the valley of kings. The find could be the biggest discovery since the discovery of the Saqqara Tomb in 2019. The tomb did not seem to have a substantial amount of valuables. This could mean that the person buried was only a lesser noble. Craig Morris told reporters that his team is working hard on uncovering whose grave this is and what period it stems from.
Morris is ecstatic about his found in Egypt: "The feeling of being the first one to enter a sacred place like that in thousands of years is one I will never forget. I'm ecstatic to have achieved something as remarkable as this." The find represents a major development in his career, he elaborates. "We're proud of the incredible feat Dr. Morris has achieved. It's a huge contribution to the study of ancient Egypt. We couldn't be happier to count him among our trusted experts. He perfectly embodies the values we want to represent", says J. Stephen Athens, founder and CEO of the IARII.
On March 14, 2018, a little-known company named Gen-Wyld announced FDA approval for a groundbreaking procedure to enhance a patient’s primary and secondary sexual characteristics using gene therapy. The company was an overnight success.
Shortly thereafter, they introduced a suite of gene-altering body modification procedures that allowed patients to make dramatic aesthetic changes to their bodies by gene-splicing “non-human” anatomy. Those daring (and wealthy) enough can now add cuttlefish pigmentation to their skin, sport a pair of fox ears, and even add a functional tail. While rare, these so-called “modders” draw plenty of hate from conservative communities.
Thanks to their revolutionary procedures, Gen-Wyld is now a household name. Norman Carlson, Gen-Wyld’s chief evangelist, recently announced the company is in the trial phase for a groundbreaking treatment for diabetes.
Yet despite their success, a shroud of secrecy surrounds Gen-Wyld. Their no-patent policy obscures the secrets of their procedures from the public eye. Financial experts claim that Gen-Wyld is run less like a traditional business and more like an NGO with some specific, unknown objective.
Some claim that they will not stop until humanity has been reduced to monstrous slaves and that Gen-Wyld’s board of directors will install themselves as inhuman overlords of the new world order.
However, until the true secrets behind Gen-Wyld are discovered, the genetic biotech firm will continue to grow, develop, and progress its grand designs.